98%
921
2 minutes
20
Introduction: Genome-wide association study identified as a candidate gene for type 1 diabetes (T1D) in Caucasians. We aimed to investigate if rs229541 in conferred susceptibility to T1D in Chinese, independent of genotypes and if this gene polymorphism affected the clinical profiles of T1D.
Methods: In this case-control study, genotypes of rs229541 were obtained from 1278 patients with T1D and 1282 nondiabetic controls using MassARRAY.
Results: Genotypic (P = 0.0210) and allelic (P = 0.0084) frequencies were significantly different between the T1D group and the control group. When the model was adjusted for genotypes, G allele carriers were observed less often in the T1D group (P = 0.0423, OR 0.82, 95% CI 0.68-0.99) than in the control group, and the G allele was associated with reduced T1D risk(P = 0.0167, OR 0.83, 95% CI 0.71-0.97). T1D patients who were homozygous for the G allele showed a higher positive rate of ZnT8A than carriers of the A allele (P = 0.0171, OR 1.88, 95% CI 1.12-3.16). By detection of fasting C-peptide, G allele carriers exhibited a lower frequency of beta-cell failure compared to those with A/A genotype (P = 0.0058, OR 0.70, 95% CI 0.54-0.90). was not found to be correlated with GADA, IA-2A or age at T1D diagnosis.
Discussion: The polymorphism in was independently associated with T1D risk in Chinese and broadly modified clinical features of the disease. This loci might be utilized to construct genetic risk model in combination with the well-known region for future screening of genetically T1D prone individuals among Chinese.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12014654 | PMC |
http://dx.doi.org/10.3389/fimmu.2025.1551552 | DOI Listing |
JAMA Pediatr
September 2025
Diabetes Research Envisioned and Accomplished in Manitoba (DREAM) Research Theme, Children's Hospital Research Institute of Manitoba, Winnipeg, Canada.
Importance: Youth living with type 1 diabetes (T1D) are increasingly choosing automated insulin delivery (AID) systems to manage their blood glucose. Few systematic reviews meta-analyzing results from randomized clinical trials (RCTs) are available to guide decision-making.
Objective: To study the association of prolonged AID system use in an outpatient setting with measures of glucose management and quality of life in youth with T1D.
Diabetes Obes Metab
September 2025
Graduate School of Physical Education, Myongji University, Yongin, Republic of Korea.
Background: High levels of glycated haemoglobin (HbA1c) in people with type 1 diabetes (T1D) are associated with high mortality and cardiovascular risk. Physical activity is an affordable intervention that is available to most people, but the type and amount of exercise to induce metabolic benefits in T1D are not known with certainty.
Objective: To determine the comparative effectiveness of diverse exercise modes and dosages to influence HbA1c in patients with T1D.
Front Physiol
August 2025
Center for Biomedical Research, National Research and Innovation Agency (BRIN), Cibinong, Indonesia.
Type 1 diabetes (T1D) is associated with severe metabolic dysregulation and organ complications such as hepatomegaly and nephropathy. While insulin therapy remains the cornerstone of treatment, there is growing interest in dietary interventions that modulate metabolic outcomes independently of insulin. This study aimed to investigate the effects of calorie restriction (CR) combined with time-restricted feeding (TRF) on metabolic and histological parameters in a high-fat diet-fed, streptozotocin-induced rat model of T1D.
View Article and Find Full Text PDFContemp Clin Trials
September 2025
University of Central Florida College of Medicine, Orlando, FL, United States of America; Division of Diabetes and Endocrinology, Department of Pediatrics, Nemours Children's Health, Orlando, FL, United States of America.
There is a critical need for efficacious interventions targeting the psychosocial and systems level barriers to successful healthcare transitions in young adults (YA) with type 1 diabetes (T1D). Transdisciplinary Care for Transition (TCT) is a novel intervention that involves conjoint delivery of T1D care by a diabetes nurse educator, social worker/transition navigator, and psychologist during the transition between pediatric and adult T1D healthcare settings. The TCT team will participate in cross discipline training, see YA jointly for three 60-min virtual visits, and collaborate in care delivery by integrating their respective knowledge and skills.
View Article and Find Full Text PDFDiabetes Metab Res Rev
September 2025
Interdisciplinary Department of Medicine, School of Medicine, University of Bari 'Aldo Moro', Bari, Italy.
Overweight and obesity represent common chronic metabolic disorders in the general population, and observed trends describe a substantial growth in the prevalence of weight excess also among individuals with type 1 diabetes (T1D), the so-called 'lean phenotype' of diabetes. The sharp rise of weight excess and obesity-related cardio-nephron-metabolic burdens observed in T2D is expected to produce similar consequences in T1D, leading to the urgent need to endorse therapeutic protocols as in most parts of the World no adjunctive treatments are approved for T1D, making weight excess management challenging in these individuals. The notable results shown by newer glucagon-like peptide 1 receptor agonists (GLP-1RAs) and emerging dual agonists, especially while managing cardio-metabolic burdens, in T2D have encouraged fervent anecdotal and non-anecdotal research also in T1D, indicating that non-insulin injective agents can be effective and safe.
View Article and Find Full Text PDF